|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | 0.00% |
|
0.00% | -75.00% |
| 04-02 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026 | CI |
| 03-05 | RAMM Pharma Corp. Reports Earnings Results for the Full Year Ended October 31, 2025 | CI |
| Market Cap | 1.79M 1.26M 1.1M 1.02M 957K 119M 1.8M 12.11M 4.69M 58.7M 4.74M 4.64M 204M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.07M 752K 657K 608K 570K 71.11M 1.08M 7.21M 2.79M 34.99M 2.83M 2.77M 122M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -62.50% | ||
| Current year | -75.00% |
| 1 month | 0.01 | 0.02 | |
| Current year | 0.01 | 0.05 | |
| 1 year | 0.01 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 1 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 08/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 30/09/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 30/09/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 30/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/06/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 20/03/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% | ||
| 20/03/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +50.00% | -70.00% | 1.26M | ||
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | ||
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | ||
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | ||
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | ||
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | ||
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | ||
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | ||
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | ||
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | ||
| Average | -0.27% | -2.71% | +23.10% | +29.03% | 330.23B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.49% | +63.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.06M 2.67M 2.47M 2.32M 289M 4.37M 29.35M 11.36M 142M 11.5M 11.25M 494M | 3.36M 2.37M 2.07M 1.91M 1.8M 224M 3.39M 22.72M 8.8M 110M 8.9M 8.71M 383M |
| Net income | -16.5M -11.63M -10.16M -9.4M -8.82M -1.1B -16.62M -112M -43.19M -541M -43.7M -42.77M -1.88B | -8.91M -6.28M -5.48M -5.08M -4.76M -594M -8.97M -60.23M -23.32M -292M -23.6M -23.09M -1.01B |
| Net Debt | -626K -441K -385K -356K -334K -41.69M -630K -4.23M -1.64M -20.51M -1.66M -1.62M -71.23M | -723K -510K -445K -412K -387K -48.2M -729K -4.89M -1.89M -23.71M -1.92M -1.88M -82.36M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















